Michelle Petri, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/24/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Boxer Capital
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    04/30/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bristol Myer Squibb
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Caribou Biosciences
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    03/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    CTI Clinical Trial
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Cullgen
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    CVS Health
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Dianthus Therapeutics
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    DualityBio
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Enexa Bio
    Topic:
    Lupus
    Date added:
    04/28/2026
    Date updated:
    04/28/2026

Pages

Return to 2026 Florida Society of Rheumatology Annual Meeting